XML 21 R124.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Consolidating Data (Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 29, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jul. 01, 2012
Apr. 01, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]                      
Net income $ 75,409 $ 162,716 $ 271,739 $ 224,129 $ 70,639 $ 134,001 $ 247,250 $ 172,035 $ 733,993 $ 623,925 $ 599,114
Income from discontinued operations, net of tax                 0 0 51,036
Income (loss) from continuing operations                 733,993 623,925 548,078
Adjustments to reconcile net income to net cash provided by operating activities:                      
Depreciation                 167,072 168,978 180,408
Amortization of deferred loan origination costs                 86,181 78,592 78,695
Amortization of financing origination fees                 9,376 9,969 10,790
Provision for employee long-term benefits                 66,877 71,347 59,441
Contributions to pension and postretirement plans                 (204,796) (244,416) (219,695)
Stock compensation expense                 41,244 40,815 38,192
Net change in wholesale finance receivables related to sales                 28,865 2,513 (2,335)
Provision for credit losses                 60,008 22,239 17,031
Loss on debt extinguishment                 4,947 4,323 9,608
Pension and postretirement healthcare plan curtailment and settlement expense                 0 6,242 236
Deferred income taxes                 52,580 128,452 87,873
Foreign currency adjustments                 16,269 9,773 10,678
Other, net                 10,123 (7,216) (15,807)
Changes in current assets and liabilities:                      
Accounts receivable                 (36,653) (13,690) 43,050
Finance receivables – accrued interest and other                 (346) (4) 5,027
Inventories                 (46,474) 21,459 (94,957)
Accounts payable and accrued liabilities                 (53,623) (10,798) 120,291
Restructuring reserves                 (25,042) (16,087) 8,072
Derivative instruments                 (2,189) 2,758 (2,488)
Prepaid and other                 68,681 (97,716) 3,103
Total adjustments                 243,100 177,533 337,213
Net cash provided by operating activities of continuing operations                 977,093 801,458 885,291
Cash flows from investing activities of continuing operations:                      
Capital expenditures                 (208,321) (189,002) (189,035)
Origination of finance receivables                 (3,244,005) (2,858,701) (2,622,024)
Collections on finance receivables                 2,831,994 2,768,089 2,760,049
Purchases of marketable securities                 (4,998) (4,993) (142,653)
Sales and redemptions of marketable securities                 40,108 23,296 130,121
Other                 16,355 0 0
Net used by investing activities of continuing operations                 (568,867) (261,311) (63,542)
Cash flows from financing activities of continuing operations:                      
Proceeds from issuance of medium-term notes                 0 993,737 447,076
Repayments of medium-term notes                 (27,858) (420,870) (59,211)
Intercompany Borrowing Activity                 0 0  
Proceeds from securitization debt                 647,516 763,895 1,082,599
Repayments of securitization debt                 (840,387) (1,405,599) (1,754,568)
Borrowings of asset-backed commercial paper                 88,456 200,417  
Net increase (decrease) in credit facilities and unsecured commercial paper                 371,085 (744,724) 237,827
Net repayments in asset-backed commercial paper                 (78,765) (24,301) (483)
Net change in restricted cash                 43,201 41,647 59,232
Dividends                 (187,688) (141,681) (111,011)
Purchase of common stock for treasury                 (479,231) (311,632) (224,548)
Excess tax benefits from share-based payments                 19,895 13,065 6,303
Issuance of common stock under employee stock option plans                 50,567 45,973 7,840
Net cash used by financing activities of continuing operations                 (393,209) (990,073) (308,944)
Effect of exchange rate changes on cash and cash equivalents                 (16,543) (8,886) (7,788)
Net (decrease) increase in cash and cash equivalents of continuing operations                     505,017
Cash flows from operating activities of discontinued operations                     0
Cash flows from investing activities of discontinued operations                     0
Effect of exchange rate changes on cash and cash equivalents of discontinued operations                     0
Net Cash Provided by (Used in) Discontinued Operations                     0
Net (decrease) increase in cash and cash equivalents from continuing operations                 (1,526) (458,812) 505,017
Cash and cash equivalents:                      
Cash and cash equivalents—beginning of period       1,068,138       1,526,950 1,068,138 1,526,950 1,021,933
Net (decrease) increase in cash and cash equivalents                 (1,526) (458,812) 505,017
Cash and cash equivalents—end of period 1,066,612       1,068,138       1,066,612 1,068,138 1,526,950
Motorcycles & Related Products Operations [Member]
                     
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]                      
Net income                 745,077 677,048 558,807
Income from discontinued operations, net of tax                 0 0 51,036
Income (loss) from continuing operations                 745,077 677,048 507,771
Adjustments to reconcile net income to net cash provided by operating activities:                      
Depreciation                 160,181 162,659 173,959
Amortization of deferred loan origination costs                 0 0 0
Amortization of financing origination fees                 473 473 473
Provision for employee long-term benefits                 66,877 67,612 55,942
Contributions to pension and postretirement plans                 (204,796) (244,416) (219,695)
Stock compensation expense                 38,367 37,544 35,404
Net change in wholesale finance receivables related to sales                 0 0 0
Provision for credit losses                 0 0 0
Loss on debt extinguishment                 0 0 0
Pension and postretirement healthcare plan curtailment and settlement expense                   6,242 236
Deferred income taxes                 54,568 117,772 71,555
Foreign currency adjustments                 16,269 9,773 10,678
Other, net                 10,942 (2,290) (16,650)
Changes in current assets and liabilities:                      
Accounts receivable                 (24,273) 9,323 60,403
Finance receivables – accrued interest and other                 0 0 0
Inventories                 (46,474) 21,459 (94,957)
Accounts payable and accrued liabilities                 (60,907) (6,368) 81,670
Restructuring reserves                 (25,042) (16,087) 8,072
Derivative instruments                 (2,161) 2,906 (2,519)
Prepaid and other                 70,900 (95,162) 1,154
Total adjustments                 54,924 71,440 165,725
Net cash provided by operating activities of continuing operations                 800,001 748,488 673,496
Cash flows from investing activities of continuing operations:                      
Capital expenditures                 (199,354) (180,416) (179,988)
Origination of finance receivables                 0 0 0
Collections on finance receivables                 0 0 0
Purchases of marketable securities                 (4,998) (4,993) (142,653)
Sales and redemptions of marketable securities                 40,108 23,296 130,121
Other                 16,355    
Net used by investing activities of continuing operations                 (147,889) (162,113) (192,520)
Cash flows from financing activities of continuing operations:                      
Proceeds from issuance of medium-term notes                   0 0
Repayments of medium-term notes                 0 0 0
Intercompany Borrowing Activity                 (50,000) (400,000)  
Proceeds from securitization debt                 0 0 0
Repayments of securitization debt                 0 0 0
Borrowings of asset-backed commercial paper                 0 0  
Net increase (decrease) in credit facilities and unsecured commercial paper                 0 0 0
Net repayments in asset-backed commercial paper                 0 0 0
Net change in restricted cash                 0 0 0
Dividends                 (187,688) (141,681) (111,011)
Purchase of common stock for treasury                 (479,231) (311,632) (224,548)
Excess tax benefits from share-based payments                 19,895 13,065 6,303
Issuance of common stock under employee stock option plans                 50,567 45,973 7,840
Net cash used by financing activities of continuing operations                 (646,457) (794,275) (321,416)
Effect of exchange rate changes on cash and cash equivalents                 (14,459) (7,714) (8,021)
Net (decrease) increase in cash and cash equivalents of continuing operations                     151,539
Cash flows from operating activities of discontinued operations                     0
Cash flows from investing activities of discontinued operations                     0
Effect of exchange rate changes on cash and cash equivalents of discontinued operations                     0
Net Cash Provided by (Used in) Discontinued Operations                     0
Net (decrease) increase in cash and cash equivalents from continuing operations                 (8,804) (215,614) 151,539
Cash and cash equivalents:                      
Cash and cash equivalents—beginning of period       727,716       943,330 727,716 943,330 791,791
Net (decrease) increase in cash and cash equivalents                 (8,804) (215,614) 151,539
Cash and cash equivalents—end of period 718,912       727,716       718,912 727,716 943,330
Financial Services Operations [Member]
                     
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]                      
Net income                 173,916 171,877 165,307
Income from discontinued operations, net of tax                 0 0 0
Income (loss) from continuing operations                 173,916 171,877 165,307
Adjustments to reconcile net income to net cash provided by operating activities:                      
Depreciation                 6,891 6,319 6,449
Amortization of deferred loan origination costs                 86,181 78,592 78,695
Amortization of financing origination fees                 8,903 9,496 10,317
Provision for employee long-term benefits                 0 3,735 3,499
Contributions to pension and postretirement plans                 0 0 0
Stock compensation expense                 2,877 3,271 2,788
Net change in wholesale finance receivables related to sales                 0 0 0
Provision for credit losses                 60,008 22,239 17,031
Loss on debt extinguishment                 4,947 4,323 9,608
Pension and postretirement healthcare plan curtailment and settlement expense                   0 0
Deferred income taxes                 (1,988) 10,680 16,318
Foreign currency adjustments                 0 0 0
Other, net                 (819) (4,926) 843
Changes in current assets and liabilities:                      
Accounts receivable                 0 0 0
Finance receivables – accrued interest and other                 (346) (4) 5,027
Inventories                 0 0 0
Accounts payable and accrued liabilities                 (5,096) (27,443) (25,989)
Restructuring reserves                 0 0 0
Derivative instruments                 (28) (148) 31
Prepaid and other                 (2,219) (2,554) 49,524
Total adjustments                 159,311 103,580 174,141
Net cash provided by operating activities of continuing operations                 333,227 275,457 339,448
Cash flows from investing activities of continuing operations:                      
Capital expenditures                 (8,967) (8,586) (9,047)
Origination of finance receivables                 (7,140,533) (6,544,828) (6,056,242)
Collections on finance receivables                 6,757,387 6,456,729 6,191,932
Purchases of marketable securities                 0 0 0
Sales and redemptions of marketable securities                 0 0 0
Other                 0    
Net used by investing activities of continuing operations                 (392,113) (96,685) 126,643
Cash flows from financing activities of continuing operations:                      
Proceeds from issuance of medium-term notes                   993,737 447,076
Repayments of medium-term notes                 (27,858) (420,870) (59,211)
Intercompany Borrowing Activity                 50,000 400,000  
Proceeds from securitization debt                 647,516 763,895 1,082,599
Repayments of securitization debt                 (840,387) (1,405,599) (1,754,568)
Borrowings of asset-backed commercial paper                 88,456 200,417  
Net increase (decrease) in credit facilities and unsecured commercial paper                 371,085 (744,724) 237,827
Net repayments in asset-backed commercial paper                 (78,765) (24,301) (483)
Net change in restricted cash                 43,201 41,647 59,232
Dividends                 (185,000) (225,000) (125,000)
Purchase of common stock for treasury                 0 0 0
Excess tax benefits from share-based payments                 0 0 0
Issuance of common stock under employee stock option plans                 0 0 0
Net cash used by financing activities of continuing operations                 68,248 (420,798) (112,528)
Effect of exchange rate changes on cash and cash equivalents                 (2,084) (1,172) (85)
Net (decrease) increase in cash and cash equivalents of continuing operations                     353,478
Cash flows from operating activities of discontinued operations                     0
Cash flows from investing activities of discontinued operations                     0
Effect of exchange rate changes on cash and cash equivalents of discontinued operations                     0
Net Cash Provided by (Used in) Discontinued Operations                     0
Net (decrease) increase in cash and cash equivalents from continuing operations                 7,278 (243,198) 353,478
Cash and cash equivalents:                      
Cash and cash equivalents—beginning of period       340,422       583,620 340,422 583,620 230,142
Net (decrease) increase in cash and cash equivalents                 7,278 (243,198) 353,478
Cash and cash equivalents—end of period 347,700       340,422       347,700 340,422 583,620
Eliminations & Adjustments [Member]
                     
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]                      
Net income                 (185,000) (225,000) (125,000)
Income from discontinued operations, net of tax                 0 0 0
Income (loss) from continuing operations                 (185,000) (225,000) (125,000)
Adjustments to reconcile net income to net cash provided by operating activities:                      
Depreciation                 0 0 0
Amortization of deferred loan origination costs                 0 0 0
Amortization of financing origination fees                 0 0 0
Provision for employee long-term benefits                 0 0 0
Contributions to pension and postretirement plans                 0 0 0
Stock compensation expense                 0 0 0
Net change in wholesale finance receivables related to sales                 28,865 2,513 (2,335)
Provision for credit losses                 0 0 0
Loss on debt extinguishment                 0 0 0
Pension and postretirement healthcare plan curtailment and settlement expense                   0 0
Deferred income taxes                 0 0 0
Foreign currency adjustments                 0 0 0
Other, net                 0 0 0
Changes in current assets and liabilities:                      
Accounts receivable                 (12,380) (23,013) (17,353)
Finance receivables – accrued interest and other                 0 0 0
Inventories                 0 0 0
Accounts payable and accrued liabilities                 12,380 23,013 64,610
Restructuring reserves                 0 0 0
Derivative instruments                 0 0 0
Prepaid and other                 0 0 (47,575)
Total adjustments                 28,865 2,513 (2,653)
Net cash provided by operating activities of continuing operations                 (156,135) (222,487) (127,653)
Cash flows from investing activities of continuing operations:                      
Capital expenditures                 0 0 0
Origination of finance receivables                 3,896,528 3,686,127 3,434,218
Collections on finance receivables                 (3,925,393) (3,688,640) (3,431,883)
Purchases of marketable securities                 0 0 0
Sales and redemptions of marketable securities                 0 0 0
Other                 0    
Net used by investing activities of continuing operations                 (28,865) (2,513) 2,335
Cash flows from financing activities of continuing operations:                      
Proceeds from issuance of medium-term notes                   0 0
Repayments of medium-term notes                 0 0 0
Intercompany Borrowing Activity                 0 0  
Proceeds from securitization debt                 0 0 0
Repayments of securitization debt                 0 0 0
Borrowings of asset-backed commercial paper                 0 0  
Net increase (decrease) in credit facilities and unsecured commercial paper                 0 0 0
Net repayments in asset-backed commercial paper                 0 0 0
Net change in restricted cash                 0 0 0
Dividends                 185,000 225,000 125,000
Purchase of common stock for treasury                 0 0 0
Excess tax benefits from share-based payments                 0 0 0
Issuance of common stock under employee stock option plans                 0 0 0
Net cash used by financing activities of continuing operations                 185,000 225,000 125,000
Effect of exchange rate changes on cash and cash equivalents                 0 0 318
Net (decrease) increase in cash and cash equivalents of continuing operations                     0
Cash flows from operating activities of discontinued operations                     0
Cash flows from investing activities of discontinued operations                     0
Effect of exchange rate changes on cash and cash equivalents of discontinued operations                     0
Net Cash Provided by (Used in) Discontinued Operations                     0
Net (decrease) increase in cash and cash equivalents from continuing operations                 0 0 0
Cash and cash equivalents:                      
Cash and cash equivalents—beginning of period       0       0 0 0 0
Net (decrease) increase in cash and cash equivalents                 0 0 0
Cash and cash equivalents—end of period $ 0       $ 0       $ 0 $ 0 $ 0